This new antibiotic may finally put a stop to some of the world's most drug-resistant pathogens
Zosurabalpin, a new antibiotic in development by Roche, shows promise in combating multi-drug resistant Gram-negative bacteria, potentially transforming treatment approaches.
This new antibiotic may finally put a stop to some of the world's most drug-resistant pathogens
Zosurabalpin, a new antibiotic in development by Roche, shows promise in combating multi-drug resistant Gram-negative bacteria, potentially transforming treatment approaches.
New drug for lower back pain could be a gamechanger'
Dr. Shiva Tripathi emphasized that if the new drug PP353 is approved, it could significantly transform the management of chronic lower back pain for a substantial patient population.